| Financial Year |
March 31 2023 |
| Monetary Funds |
2,795,728,607.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
23,791,611,005.45 |
| Advances to Suppliers |
124,410,875.13 |
| Other Receivables |
14,781,843.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,617,938,340.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,758,947.44 |
| Total Current Assets |
36,415,229,618.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
9,951,731.98 |
| Fixed Assetes |
3,002,101,333.68 |
| Under-construction Projects |
1,743,089,366.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
347,478,618.09 |
| R&D expenses |
730,314,046.43 |
| Goodwill |
19,279,096.95 |
| Long-Term Deferred and Prepaid Expenses |
36,321,441.29 |
| Deferred Income Tax Assets |
206,680,129.53 |
| Other Non-Current Assets |
410,886,436.29 |
| Sub-Total of Non-Current Assets |
6,827,199,136.38 |
| Total Assets |
43,242,428,755.31 |
| Short-Term Loans |
3,780,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,421,600.00 |
| Accounts Payable |
11,277,665,455.52 |
| Accounts Received In Advance |
12,815,193.38 |
| Employee Compensation Payable |
36,526,797.06 |
| Taxes Payable |
1,013,267,467.01 |
| Interest Payable |
2,813,195.84 |
| Dividend Payable |
-- |
| Other payables |
230,002,714.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,892,359.73 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
16,363,591,587.24 |
| Long-term Loans |
275,061,431.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
60,760,980.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
610,600,005.74 |
| Total Liabilities |
16,974,191,592.98 |
| Paid-In Capital(Or Share Stock) |
1,600,000,000.00 |
| Capital Surplus |
207,964,774.94 |
| Surplus Reserve |
800,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
23,660,272,387.39 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,268,237,162.33 |
| Owner's Equity（Stockholder's Equity） |
26,268,237,162.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
43,242,428,755.31 |
